title: Clinical analysis of anti-NR2 glutamate receptor antibodies and interleukin-6 with neuropsychiatric systemic lupus erythematosus.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Sato
authors.forename: Hisashi
authors.initials: H
authors.lastname: Kawashima
authors.forename: Akinori
authors.initials: A
authors.lastname: Hoshika
authors.forename: Taku
authors.initials: T
authors.lastname: Yoshio
mesh_terms: D000293:Adolescent; D000925:Anticoagulants / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D015850:Interleukin-6 / Q000097:blood*; D020945:Lupus Vasculitis, Central Nervous System / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*
chemical_list: D000925:Anticoagulants; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D015850:Interleukin-6; C120997:NR2A NMDA receptor; D016194:Receptors, N-Methyl-D-Aspartate; D016572:Cyclosporine; D008775:Methylprednisolone